Finance
Week In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-Star
Deals and Financings invoX Pharma, a Sino Biopharm (OTCPK:SBMFF) (OTCPK:SBHMY) (HK: 1177) subsidiary, will pay $161 million to acquire F-Star (FSTX), …
Deals and Financings invoX Pharma, a Sino Biopharm (OTCPK:SBMFF) (OTCPK:SBHMY) (HK: 1177) subsidiary, will pay $161 million to acquire F-Star (FSTX), …
